IREIT Global (SGX:UD1U)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.2950
0.00 (0.00%)
Aug 1, 2025, 4:45 PM SGT
Market Cap396.73M
Revenue (ttm)106.78M
Net Income (ttm)12.16M
Shares Out1.34B
EPS (ttm)0.01
PE Ratio32.64
Forward PE10.63
Dividend0.03 (9.56%)
Ex-Dividend DateMar 5, 2025
Volume331,600
Average Volume889,360
Open0.2950
Previous Close0.2950
Day's Range0.2900 - 0.2950
52-Week Range0.2250 - 0.3200
Beta0.66
RSI53.14
Earnings DateAug 1, 2025

About Revance Therapeutics

IREIT Global (SGX-UD1U) which was listed on 13 August 2014, is the first Singapore-listed real estate investment trust with the investment strategy of principally investing, directly or indirectly, in a portfolio of income-producing real estate in Europe which is or will be primarily used for office, retail, industrial (including logistics and business parks), hospitality, hospitality-related and other accommodation and/or lodging purposes, as well as real estate-related assets. IREIT Global’s current portfolio comprises five freehold office pr... [Read more]

Industry REIT - Office
CEO Peter Viens
Country Singapore
Stock Exchange Singapore Exchange
Ticker Symbol UD1U
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.